Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus.

In type 2 diabetes mellitus there is a progressive loss of beta-cell function. One new approach yielding promising results is the use of the orally active dipeptidyl peptidase-4 (DPP-4) inhibitors like sitagliptin and vildagliptin.